FDA is convening a series of consultation meetings with patient stakeholders to address key considerations and challenges in establishing a process for conducting a series of patient-focused drug development meetings that will be useful to both the patient community and FDA.
- Prescription Drug User Fee Act; Patient-Focused Drug Development; Consultation Meetings; Request for Notification of Patient Stakeholder Intention to Participate (posted 9/24/2012)
- November 20, 2013 Meeting Minutes
- July 18, 2013 Meeting Minutes
- April 19, 2013 Meeting Minutes
- February 27, 2013 Meeting Minutes
- December 11, 2012 Meeting Minutes
- October 10, 2012 Meeting Minutes